Linked Life Data

19880688

Source:http://linkedlifedata.com/resource/pubmed/id/19880688

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2009-11-2
pubmed:abstractText
To examine clinical characteristics, laboratory features, and outcomes of patients with lupus-like syndrome attributable to anti-tumor necrosis factor alpha (TNF-alpha) therapy.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-14699483, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-15252064, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-15370396, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-15535831, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-15552528, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-15627197, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-15899041, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-16126996, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-16357696, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-16373256, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-16425572, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-17153847, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-17153848, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-17223874, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-17349557, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-17632266, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-17980456, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-18200008, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-18226185, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-18589191, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880688-9324032
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1942-5546
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
84
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
979-84
pubmed:dateRevised
2010-9-28
pubmed:meshHeading
pubmed-meshheading:19880688-Academic Medical Centers, pubmed-meshheading:19880688-Age Distribution, pubmed-meshheading:19880688-Antibodies, Monoclonal, pubmed-meshheading:19880688-Crohn Disease, pubmed-meshheading:19880688-Dose-Response Relationship, Drug, pubmed-meshheading:19880688-Drug Administration Schedule, pubmed-meshheading:19880688-Female, pubmed-meshheading:19880688-Follow-Up Studies, pubmed-meshheading:19880688-Humans, pubmed-meshheading:19880688-Incidence, pubmed-meshheading:19880688-Infusions, Intravenous, pubmed-meshheading:19880688-Lupus Erythematosus, Systemic, pubmed-meshheading:19880688-Male, pubmed-meshheading:19880688-Middle Aged, pubmed-meshheading:19880688-Minnesota, pubmed-meshheading:19880688-Retrospective Studies, pubmed-meshheading:19880688-Risk Assessment, pubmed-meshheading:19880688-Sampling Studies, pubmed-meshheading:19880688-Sex Distribution, pubmed-meshheading:19880688-Syndrome, pubmed-meshheading:19880688-Time Factors, pubmed-meshheading:19880688-Tumor Necrosis Factor-alpha
pubmed:year
2009
pubmed:articleTitle
Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic.
pubmed:affiliation
Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA. wetter.david@mayo.edu
pubmed:publicationType
Journal Article